Skip to main content
. 2022 Jun 27;55(9):923–937. doi: 10.1111/iej.13786

TABLE 2.

Descriptive data of control and treatment groups

Controls Pre‐treatment 1‐year post‐treatment

p‐Value

Control vs. pre‐treatment

Gender

Male n = 18

Female n = 32

Male n = 24

Female n = 41

Age 32.4 (19–51) 43.3 (24–75)
Height (cm) 166.50 ± 9.04 169.60 ± 9.70
Weight (kg) 67.73 ± 11.00 75.36 ± 14.99
BMI (kg/m2) 24.39 ± 3.23 26.14 ± 4.40 p = .031
Waist circumference (cm) 79.14 ± 10.19 82.5 ± 11.10 p = .178
Systolic blood pressure (mmHg) 120 (110–135) 121 (100–159)
Diastolic blood pressure (mmHg) 75 (61–87) 78 (54–115)
HbA1C (%) 4.30 (4.0–7.4) 4.9 (4.30–6.10) 4.95 (4.0–7.70) p = .0005
Total cholesterol (mmol/L) 5.32 (2.62–8.39) 5.95 (2.59–10.21) 5.28 (2.59–8.88) p = .054
HDL (mmol/L) 1.91 (0.98–2.99) 1.93 (1.02–3.11) 1.55 (1.03–3.11) p = .934
LDL (mmol/L) 2.74 (1.0–5.07) 3.47 (0.77–6.35) 2.82 (0.70–6.18) p = .0096
Triglycerides (mmol/L) 0.84 (0.57–5.65) 1.04 (0.57–2.56) 1.29 (0.57–5.65) p = .0035
TC/HDL (mmol/L) 2.65 (1.50–4.90) 3.0 (1.66–5.30) 3.45 (1.64–5.90)

Note: The values are given as Mean ± Standard Deviation; Median (Minimum–Maximum).